Francisco Diaz-Mitoma
2022
In 2022, Francisco Diaz-Mitoma earned a total compensation of $1M as Chief Medical Officer at VBI Vaccines, a 46% decrease compared to previous year.
Compensation breakdown
| Bonus | $83,062 |
|---|---|
| Option Awards | $461,188 |
| Salary | $461,455 |
| Total | $1,005,705 |
Diaz-Mitoma received $461.5K in salary, accounting for 46% of the total pay in 2022.
Diaz-Mitoma also received $83.1K in bonus and $461.2K in option awards.
Rankings
In 2022, Francisco Diaz-Mitoma's compensation ranked 3,002nd out of 5,672 executives tracked by ExecPay. In other words, Diaz-Mitoma earned more than 47.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,002 out of 5,672 | 47th |
Division Manufacturing | 1,683 out of 3,081 | 45th |
Major group Chemicals And Allied Products | 788 out of 1,396 | 44th |
Industry group Drugs | 735 out of 1,297 | 43rd |
Industry Pharmaceutical Preparations | 530 out of 940 | 44th |
Source: SEC filing on May 1, 2023.
Diaz-Mitoma's colleagues
We found two more compensation records of executives who worked with Francisco Diaz-Mitoma at VBI Vaccines in 2022.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019